Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Bloomin’ Brands could blossom in 2024: https://www.marketbeat.com/logos/articles/med_20240223074736_chart-blmn-2232024ver001.png
Bloomin’ Brands could blossom in 2024

Bloomin’ Brands (NASDAQ: BLMN) served mixed results for Q4 and provided tepid guidance, but repositioning efforts have the restaurant stock set up to blossom in 2024. A massive closure effort

Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73699/AC-230224.001.png
Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. 415% Biotech Hot Stock nach 15.973% mit BioNTech

 

23.02.24 08:03

AC Research

 

London (www.aktiencheck.de , Anzeige)

 

Keurig-Dr Pepper stock: Time to take another sip?: https://www.marketbeat.com/logos/articles/med_20240222121921_chart-kdp-2222024ver001.png
Keurig-Dr Pepper stock: Time to take another sip?

Keurig Dr Pepper's (NASDAQ: KDP) share price fell following the Q4 results and guidance for 2024, setting up the next buying opportunity. The market is down but aligning with a bottoming pattern

Rivian shares gets discounted; shares can move lower: https://www.marketbeat.com/logos/articles/med_20240222100045_chart-rivn-2222024ver001.png
Rivian shares gets discounted; shares can move lower

Rivian’s (NASDAQ: RIVN) Q4 release further proves that the EV market bubble has burst. Internal metrics and guidance suggest demand has peaked and current capacity is too much. The takeaway is

Top-Rated AMD nears major breakout level: https://www.marketbeat.com/logos/articles/med_20240222062548_amd.jpg
Top-Rated AMD nears major breakout level

While shares of Advanced Micro Devices (NASDAQ: AMD) might not grab the headlines as much as its competitor, Nvidia (NASDAQ: NVDA), shareholders of the global semiconductor company are undoubtedly

AI powerhouse NVIDIA will hit $1000 soon: https://www.marketbeat.com/logos/articles/med_20240222065539_chart-nvda-2222024ver001.png
AI powerhouse NVIDIA will hit $1000 soon

Traders and investors fearing an NVIDIA (NASDAQ: NVDA)-led market correction can put those fears to rest. The company’s Q4 results reveal that the AI market is still strong, stronger than expected

How to use iron condors to collect income from stock options: https://www.marketbeat.com/logos/articles/med_20240221122132_iron-intc.jpg
How to use iron condors to collect income from stock options

Achieving risk-free passive income from the stock market is the dream of investors. Unfortunately, nothing in the stock market are risk-free. However, if you are willing to have a cap on your

Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73679/aktiencheck22022401.001.png
Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. 400% Biotech Aktientip nach 9.290% mit Novo-Nordisk

 

22.02.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

3 Reasons the Capital One-Discover merger is a big deal: https://www.marketbeat.com/logos/articles/med_20240221114956_3-reasons-the-capital-one-discover-merger-is-a-big.jpg
3 Reasons the Capital One-Discover merger is a big deal

What’s in your wallet? In the not-so-distant future, it might be a card issued by the combined entity of Capital One Financial Corp. (NYSE: COF) and Discover Financial Services (NYSE: DFS)

Spotify sounding better to analysts as company tunes into profits: https://www.marketbeat.com/logos/articles/med_20240220131029_spotify-sounding-better-to-analysts-as-company-tun.jpg
Spotify sounding better to analysts as company tunes into profits

Spotify Technology S.A. (NYSE: SPOT) is trading at its best levels since December 2021 on the strength of hardy revenue growth and a return to profitability. 

Spotify is a global music streaming

Informatica charges ahead on AI-driven data management tailwinds: https://www.marketbeat.com/logos/articles/med_20240218153655_charts-infa.jpg
Informatica charges ahead on AI-driven data management tailwinds

Informatica Inc. (NASDAQ: INFA) offers its artificial intelligence (AI) platform for enterprises to unify and manage their data to unlock transformative outcomes. The computer and technology

Eilt: Durchbruch in Krebsforschung: 100 mal wirksamer gegen Krebs. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73659/aktiencheck210224.001.png
Eilt: Durchbruch in Krebsforschung: 100 mal wirksamer gegen Krebs. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Durchbruch in Krebsforschung: 100 mal wirksamer gegen Krebs. Neuer 407% Biotech Hot Stock nach 15973% mit BioNTech

 

21.02.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Walmart’s uptrend is intact; buy it when it dips: https://www.marketbeat.com/logos/articles/med_20240220072702_chart-wmt-2202024ver001.png
Walmart’s uptrend is intact; buy it when it dips

Walmart (NYSE: WMT) is in an uptrend and will likely continue. The Q4 results and guidance for 2024 underpin an expectation for capital returns and improving shareholder value for this retail

These 5 stocks have unique competitive edge and room to run: https://www.marketbeat.com/logos/articles/med_20240219114803_these-5-stocks-have-unique-competitive-edge-and-ro.jpg
These 5 stocks have unique competitive edge and room to run

A prominent investment theme of the past year is the outperformance of profitable companies with a unique competitive advantage.

Obvious examples of stocks in that category include Nvidia Corp.

Higher VIX just made Realty Income’s 6% dividend better: https://www.marketbeat.com/logos/articles/med_20240219114215_higher-vix-just-made-realty-incomes-6-dividend-bet.jpg
Higher VIX just made Realty Income’s 6% dividend better

Patient investors look for safer stocks when the VIX begins to pop to protect their portfolio or expose themselves to high-quality assets at potential discountsRealty Income (NYSE: O) could be

Warren Buffett goes ex-tech and pro-oil, sell Apple buy Chevron?: https://www.marketbeat.com/logos/articles/med_20240219110132_warren-buffett-goes-ex-tech-and-pro-oil-sell-apple.jpg
Warren Buffett goes ex-tech and pro-oil, sell Apple buy Chevron?

Every market brings you a cycle to take advantage of, that is for sure, and there will always be cycles to come. Warren Buffett has been quoted saying that timing the market can turn out to be a

Sensation: 100 mal wirksamer gegen Krebs - Neuer 343% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73641/AC_VidacPharma_200224.001.png
Sensation: 100 mal wirksamer gegen Krebs - Neuer 343% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Sensation: 100 mal wirksamer gegen Krebs - Neuer 343% Biotech Hot Stock. Nach 15973% mit BioNTech und 134452% mit Biogen

 

20.02.24 08:03

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Best restaurant stocks to buy now: https://www.marketbeat.com/logos/articles/med_20240219102454_best-restaurant-stocks-to-buy-now.jpg
Best restaurant stocks to buy now

Sinking your teeth into a juicy burger from your favorite fast-food chain is comfort food at its finest. But as an investor, capitalizing on a flourishing restaurant empire may prove even more

Can UnitedHealth Group afford to keep Medicare Advantage plans?: https://www.marketbeat.com/logos/articles/med_20240218165851_can-unitedhealth-group-afford-to-keep-medicare-adv.jpg
Can UnitedHealth Group afford to keep Medicare Advantage plans?

Medicare Advantage plans have been making headlines in 2024, but not in a positive light, at least for health insurance companies. Medicare is a government-sponsored health insurance benefit

Marathon Oil stock is the place to be if you need value: https://www.marketbeat.com/logos/articles/med_20240218155954_marathon-oil-stock-is-the-place-to-be-if-you-need.jpg
Marathon Oil stock is the place to be if you need value

Not all stocks are created equal, and this year energy stocks could quickly become the market's favorite. A once-in-a-cycle opportunity to line up your portfolio with all the macro forces at play

Eilt: Krebsmedikament bis zu 100 mal wirksamer - Kursrallye voraus. Neuer 343% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73629/Aktiencheck190224.001.png
Eilt: Krebsmedikament bis zu 100 mal wirksamer - Kursrallye voraus. Neuer 343% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Krebsmedikament bis zu 100 mal wirksamer - Kursrallye voraus. Neuer 343% Biotech Hot Stock nach 134452% mit Biogen

 

19.02.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Cisco Systems stock: Income investors buy the dip: https://www.marketbeat.com/logos/articles/med_20240215120254_chart-csco-2152024ver001.png
Cisco Systems stock: Income investors buy the dip

Cisco Systems (NASDAQ: CSCO) issued a decent FQ2 report but guided lower for Q3, leaving the market less than inspired. However cold the guide, someone is stepping into the buy the dip, and it

Arista Networks stock soars past big tech rival Cisco: https://www.marketbeat.com/logos/articles/med_20240215184947_arista-networks-stock-soars-past-big-tech-rival-ci.jpg
Arista Networks stock soars past big tech rival Cisco

Arista Networks Inc. (NYSE: ANET) may not be as well known among tech investors as Cisco (NASDAQ: CSCO), but it's outperformed its larger rival by a wide margin in the past year.

Arista posted

Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 343% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73623/AC-160224.001.png